Epigenetic progression of columnar cell lesions of the breast to invasive breast cancer. (Q53262835)

12 May 2018

title

Epigenetic progression of columnar cell lesions of the breast to invasive breast cancer. (English)

1 reference

12 May 2018

author name string

Anoek H J Verschuur-Maes

series ordinal

1

1 reference

12 May 2018

Peter C de Bruin

series ordinal

2

1 reference

12 May 2018

Paul J van Diest

series ordinal

3

1 reference

12 May 2018

language of work or name

English

0 references

publication date

27 October 2012

1 reference

12 May 2018

Breast Cancer Research and Treatment

published in

1 reference

12 May 2018

volume

136

1 reference

12 May 2018

issue

3

1 reference

12 May 2018

page(s)

705-715

1 reference

12 May 2018

https://scigraph.springernature.com/pub.10.1007/s10549-012-2301-4

exact match

0 references

cites work

Histological and biological evolution of human premalignant breast disease

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2301-4

Alterations of gene expression in the development of early hyperplastic precursors of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2301-4

Columnar cell lesions of the breast: the missing link in breast cancer progression? A morphological and molecular analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2301-4

Columnar Cell Lesions of the Breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2301-4

Columnar cell lesions on breast needle biopsies: is surgical excision necessary? A systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2301-4

Invasive tubular carcinoma of the breast frequently is clonally related to flat epithelial atypia and low-grade ductal carcinoma in situ.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2301-4

Molecular alterations in columnar cell lesions of the breast.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2301-4

Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2301-4

The epigenomics of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2301-4

The epigenetics of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2301-4

Simultaneous analysis of the methylation profile of 26 cancer related regions in invasive breast carcinomas by MS-MLPA and drMS-MLPA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2301-4

DNA methylation and breast carcinogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2301-4

Changes in CpG islands promoter methylation patterns during ductal breast carcinoma progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2301-4

Methylation of CpG islands of p16(INK4a) and cyclinD1 overexpression associated with progression of intraductal proliferative lesions of the breast.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2301-4

Promoter CpG island hypermethylation during breast cancer progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2301-4

No consent should be needed for using leftover body material for scientific purposes. For.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2301-4

Methylation profiles of hereditary and sporadic ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2301-4

Is gastric cancer part of the tumour spectrum of hereditary non-polyposis colorectal cancer? A molecular genetic study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2301-4

Epigenetic signatures of familial cancer are characteristic of tumor type and family category.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2301-4

Methylation is less abundant in BRCA1-associated compared with sporadic breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2301-4

Analysis of loss of heterozygosity in 399 premalignant breast lesions at 15 genetic loci

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2301-4

Expression of miR-21 and its targets (PTEN, PDCD4, TM1) in flat epithelial atypia of the breast in relation to ductal carcinoma in situ and invasive carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2301-4

Chromosomal alterations in pure nonneoplastic breast lesions: implications for breast cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2301-4

Lack of RUNX3 inactivation in columnar cell lesions of breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2301-4

DNA methylation of RASSF1A, HIN‐1, RAR‐β, Cyclin D2 and Twist in in situ and invasive lobular breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2301-4

Frequent aberrant DNA methylation of ABCB1, FOXC1, PPP2R2B and PTEN in ductal carcinoma in situ and early invasive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2301-4

Differences and molecular immunohistochemical parameters in the subtypes of infiltrating ductal breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2301-4

Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2301-4

Methylation target array for rapid analysis of CpG island hypermethylation in multiple tissue genomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2301-4

Tumor suppressor genes are frequently methylated in lymph node metastases of breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2301-4

Quantification of CpG island methylation in progressive breast lesions from normal to invasive carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2301-4

Promoter methylation-associated loss of ID4 expression is a marker of tumour recurrence in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2301-4

Aberrant hypermethylation of ID4 gene promoter region increases risk of lymph node metastasis in T1 breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2301-4

DNA hypermethylation in breast cancer and its association with clinicopathological features.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2301-4

Nonrandom distribution of aberrant promoter methylation of cancer-related genes in sporadic breast tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2301-4

Aberrant methylation of HIN-1 (high in normal-1) is a frequent event in many human malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2301-4

Frequent epigenetic inactivation of Wnt antagonist genes in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2301-4

Epigenetic inactivation of the secreted frizzled-related protein-5 (SFRP5) gene in human breast cancer is associated with unfavorable prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2301-4

10.1007/S10549-012-2301-4

21 January 2018

Identifiers

DOI

1 reference

12 May 2018

PubMed ID

23104224

1 reference

12 May 2018